معرفی
Lance Liotta is a Professor and Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University's School of Systems Biology, where he has led transformative research since 2005 after a distinguished NIH career spanning roles as Chief of NCI's Laboratory of Pathology and Deputy Director of NIH.
His PhD in Biomedical Engineering from Case Western Reserve University established foundational work on cancer metastasis modeling. Current research focuses on proteomics-driven diagnostics and therapeutics, highlighted by inventions like Laser Capture Microdissection (Smithsonian Collection) and Reverse Phase Protein Microarrays.
Recent publications (2024-2025) reveal dominant themes in extracellular vesicle biology across cancer and infectious diseases, with strong emphasis on mitophagy mechanisms, Lyme/Chagas disease diagnostics, and machine learning integration for biomarker discovery in breast/gastric cancers. The work bridges molecular profiling with clinical applications through CAPMM's technology pipeline.
Major scientific recognition includes:
- Outstanding Virginia Faculty Award (2015)
- Flemming Award for Cancer Research
- Warner-Lambert Parke Davis Award
- Surgeon General’s Medallion
- ISI Highly Cited Investigator status
With over 690 publications and 100+ patents, Liotta has secured extensive grant funding enabling clinical translation through spin-offs Theranostics Health and Ceres Nanosciences. His mentorship at CAPMM has cultivated numerous researchers, though specific advisees aren't documented in source materials.
CAPMM operates as a multidisciplinary engine advancing proteomic technologies from basic discovery (e.g., secretory mitophagy pathways) to clinical implementation, with active trials targeting early cancer detection and personalized therapy through molecular profiling of tissue, cells, and biofluids.
